rs35168378
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_022773.4(LMF1):c.1091G>A(p.Arg364Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0268 in 1,608,236 control chromosomes in the GnomAD database, including 687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_022773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMF1 | NM_022773.4 | c.1091G>A | p.Arg364Gln | missense_variant | 8/11 | ENST00000262301.16 | NP_073610.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMF1 | ENST00000262301.16 | c.1091G>A | p.Arg364Gln | missense_variant | 8/11 | 5 | NM_022773.4 | ENSP00000262301.12 |
Frequencies
GnomAD3 genomes AF: 0.0281 AC: 4278AN: 152170Hom.: 60 Cov.: 33
GnomAD3 exomes AF: 0.0245 AC: 5902AN: 240702Hom.: 112 AF XY: 0.0251 AC XY: 3310AN XY: 131722
GnomAD4 exome AF: 0.0266 AC: 38788AN: 1455948Hom.: 627 Cov.: 32 AF XY: 0.0270 AC XY: 19525AN XY: 724404
GnomAD4 genome AF: 0.0281 AC: 4282AN: 152288Hom.: 60 Cov.: 33 AF XY: 0.0280 AC XY: 2088AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 01, 2019 | This variant is associated with the following publications: (PMID: 31619059, 30037590, 33111339) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Jul 26, 2019 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at